Al-Ali HK - Search Results

1

Biglycan as a mediator of proinflammatory response and target for MDS and sAML therapy.

Vaxevanis CK, Bauer M, Subbarayan K, Friedrich M, Massa C, Biehl K, Al-Ali HK, Wickenhauser C, Seliger B. Vaxevanis CK, et al. Oncoimmunology. 2022 Dec 15;12(1):2152998. doi: 10.1080/2162402X.2022.2152998. eCollection 2023. Oncoimmunology. 2022. PMID: 36531688 Free PMC article.

2

JAK2V617F molecular remission in a primary myelofibrosis patient treated with ruxolitinib.

Koehler A, Hubert K, Lange T, Siebolts U, Wickenhauser C, Gopalakrishna P, Niederwieser D, Monecke A, Al-Ali HK. Koehler A, et al. Ann Hematol. 2015 Nov;94(11):1929-30. doi: 10.1007/s00277-015-2454-4. Epub 2015 Jul 23. Ann Hematol. 2015. PMID: 26202608 No abstract available.

3

Aggressive systemic mastocytosis: a diagnostic challenge in a patient with myotonic dystrophy type 2: a case report.

Tran CLH, Jaekel N, Bauer M, Emmer A, Wickenhauser C, Al-Ali HK. Tran CLH, et al. Ann Hematol. 2019 Dec;98(12):2825-2827. doi: 10.1007/s00277-019-03828-2. Epub 2019 Nov 9. Ann Hematol. 2019. PMID: 31705184 No abstract available.

4

Expression, Regulation and Function of microRNA as Important Players in the Transition of MDS to Secondary AML and Their Cross Talk to RNA-Binding Proteins.

Bauer M, Vaxevanis C, Heimer N, Al-Ali HK, Jaekel N, Bachmann M, Wickenhauser C, Seliger B. Bauer M, et al. Int J Mol Sci. 2020 Sep 27;21(19):7140. doi: 10.3390/ijms21197140. Int J Mol Sci. 2020. PMID: 32992663 Free PMC article. Review.

5

Altered Spatial Composition of the Immune Cell Repertoire in Association to CD34⁺ Blasts in Myelodysplastic Syndromes and Secondary Acute Myeloid Leukemia.

Bauer M, Vaxevanis C, Al-Ali HK, Jaekel N, Naumann CLH, Schaffrath J, Rau A, Seliger B, Wickenhauser C. Bauer M, et al. Cancers (Basel). 2021 Jan 7;13(2):186. doi: 10.3390/cancers13020186. Cancers (Basel). 2021. PMID: 33430322 Free PMC article.

6

Azacitidine-induced reconstitution of the bone marrow T cell repertoire is associated with superior survival in AML patients.

Grimm J, Simnica D, Jäkel N, Paschold L, Willscher E, Schulze S, Dierks C, Al-Ali HK, Binder M. Grimm J, et al. Blood Cancer J. 2022 Jan 28;12(1):19. doi: 10.1038/s41408-022-00615-7. Blood Cancer J. 2022. PMID: 35091554 Free PMC article. Clinical Trial.

7

Long-Term Efficacy and Safety of Luspatercept for Anemia Treatment in Patients With Lower-Risk Myelodysplastic Syndromes: The Phase II PACE-MDS Study.

Platzbecker U, Götze KS, Kiewe P, Germing U, Mayer K, Radsak M, Wolff T, Chromik J, Sockel K, Oelschlägel U, Haase D, Illmer T, Al-Ali HK, Silling G, Reynolds JG, Zhang X, Attie KM, Shetty JK, Giagounidis A. Platzbecker U, et al. J Clin Oncol. 2022 Nov 20;40(33):3800-3807. doi: 10.1200/JCO.21.02476. Epub 2022 Aug 23. J Clin Oncol. 2022. PMID: 35998303 Free PMC article. Clinical Trial.

8

Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors.

Hegenbart U, Niederwieser D, Sandmaier BM, Maris MB, Shizuru JA, Greinix H, Cordonnier C, Rio B, Gratwohl A, Lange T, Al-Ali H, Storer B, Maloney D, McSweeney P, Chauncey T, Agura E, Bruno B, Maziarz RT, Petersen F, Storb R. Hegenbart U, et al. J Clin Oncol. 2006 Jan 20;24(3):444-53. doi: 10.1200/JCO.2005.03.1765. Epub 2005 Dec 12. J Clin Oncol. 2006. PMID: 16344316

9

Rapid progression of Myelodysplastic syndrome to acute myeloid leukemia on sequential azathioprine, IFN-beta and copolymer-1 in a patient with multiple sclerosis.

Then Bergh F, Niklas A, Strauss A, von Ahsen N, Niederwieser D, Schwarz J, Wagner A, Al-Ali HK. Then Bergh F, et al. Acta Haematol. 2006;116(3):207-10. doi: 10.1159/000094683. Acta Haematol. 2006. PMID: 17016041

10

Low-dose total body irradiation-based regimens as a preparative regimen for allogeneic haematopoietic cell transplantation in acute myelogenous leukaemia.

Al-Ali H, Cross M, Lange T, Freund M, Dölken G, Niederwieser D. Al-Ali H, et al. Curr Opin Oncol. 2009 Jun;21 Suppl 1:S17-22. doi: 10.1097/01.cco.0000357470.91584.62. Curr Opin Oncol. 2009. PMID: 19561407

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

103 results

Search Page